The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted.
Business development initiatives – such as through innovative product development, clever licensing deals or smart legal manoeuvres – are at the heart of the Global Generics & Biosimilars Awards.
Equally important will be recognising the industries’ best executives and leading companies.
Every Award will effectively underscore the efforts made by the global generics and biosimilars industries to make more affordable medicines available to more people everywhere.
The Awards will be presented for the fifth time on 9 October 2018 in Madrid, Spain.
The deadline for entries is 13 July, 2018.